In fiscal year 2025, SAMIK PHARM (014950) reported revenue of 60.0 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 60.0 billion KRW | 3.3 billion KRW | -755 million KRW | [source] |
| 2024 | 55.9 billion KRW | 3.7 billion KRW | 3.5 billion KRW | — |
| 2023 | 51.2 billion KRW | 2.8 billion KRW | 3.0 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 84.3 billion KRW | 14.8 billion KRW | 69.4 billion KRW | [source] |
| 2024 | — | — | — | — |
| 2023 | — | — | — | — |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|---|---|---|---|
| 2025 | 2.1 billion KRW | -1.2 billion KRW | -256 million KRW | [source] |
| 2024 | — | — | — | — |
| 2023 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.
Cash flow figures for the relevant year were not collected.